Catalog No.
Product Name
Application
Product Information
Citations
-
Antibiotic
Methicillin is a narrow-spectrum β-lactam antibiotic that targets and inhibits penicillin-binding proteins (PBPs). Its efficacy is primarily observed against Staphylococcus aureus and Staphylococcus epidermidis strains that exhibit resistance to other penicillins. Methicillin is utilized in research investigating various conditions, including skin infections, osteomyelitis, and endocarditis. -
Antibiotic
Methicillin sodium hydrate is a narrow-spectrum β-lactam antibiotic that targets penicillin-binding proteins (PBPs) to inhibit bacterial cell wall synthesis. Effective against Staphylococcus aureus and Staphylococcus epidermidis, particularly strains resistant to other penicillins, it is utilized in researching conditions such as skin infections, osteomyelitis, and endocarditis. -
Antibiotic
Rifalazil, a rifamycin derivative, targets bacterial DNA-dependent RNA polymerase, specifically inhibiting the β-subunit to disrupt RNA synthesis and induce bacterial cell death. This antibiotic demonstrates exceptional potency against mycobacteria, gram-positive bacteria, Helicobacter pylori, Chlamydia pneumoniae, and Chlamydia trachomatis, with MIC values ranging from 0.00025 to 0.0025 μg/ml. Rifalazil shows promising potential for applications in treating Chlamydia infections, Clostridium difficile-associated diarrhea (CDAD), and tuberculosis (TB). -
Antibiotic
Phleomycin is a copper-dependent antibiotic known for its DNA-damaging properties. It exerts its biological activity by binding to DNA and generating reactive oxygen species (ROS) in the presence of reducing agents, leading to both single-strand and double-strand breaks. This compound is extensively utilized in cancer research, microbial genetic transformation, serving as a screening marker to enhance fungal transformation efficiency, and the study of DNA repair mechanisms. -
Quinolone Antibiotic
Danofloxacin is a quinolone antibiotic that primarily targets bacterial DNA gyrase, leading to the inhibition of DNA replication and transcription. This mechanism disrupts the growth and proliferation of bacteria. Danofloxacin is effective against a range of bacterial infections, including those caused by Escherichia coli, Mycoplasma, and other pathogenic organisms, making it a valuable tool for related research applications. -
Macrolide Antibiotic
Erythromycin lactobionate is a macrolide antibiotic that targets bacterial 50S ribosomal subunits, inhibiting RNA-dependent protein synthesis through obstruction of transpeptidation and/or translocation processes. This compound demonstrates a broad spectrum of antimicrobial activity, making it valuable for various bacterial infections. Additionally, erythromycin lactobionate has shown potential antitumor and neuroprotective effects, presenting opportunities for research in oncology and neurobiology. -
Antibiotic
Pefloxacin is a broad-spectrum antibiotic that targets DNA gyrase, effectively inhibiting DNA replication. It exhibits significant antibacterial activity against Escherichia coli, Pseudomonas aeruginosa, and Bacteroides fragilis, with MIC90 values of 0.12, 4, and 16 mg/L, respectively. In addition to its antibacterial properties, Pefloxacin has demonstrated efficacy in reducing Plasmodium yoelii infections and may enhance UVA-induced edema and immunosuppression. This compound is suitable for various infection-related research applications. -
Bacteria Antibiotic
Nogalamycin is an anthracyclinone antibiotic that primarily targets Gram-positive bacteria. It exhibits significant antibacterial activity along with cytotoxic effects against specific tumor cells. Derived from Streptomyces nogalater var. nogalater, Nogalamycin selectively inhibits RNA synthesis by binding to the DNA template. This compound is valuable for research into anticancer therapeutics and bacterial resistance mechanisms. -
Ansamycin Antibiotic
Rifamycin is an orally active ansamycin antibiotic that primarily inhibits DNA-dependent RNA synthesis. It demonstrates significant antibacterial activity against Mycobacterium tuberculosis and can also affect hepatic bile acid metabolism. Additionally, Rifamycin exhibits anti-inflammatory properties, making it useful in the study of infections caused by Mycobacterium tuberculosis and Bacteroides fragilis, as well as in research involving lipopolysaccharide-induced inflammation. -
Antibiotic
Holomycin is a secondary metabolite belonging to the dithiolopyrrolone class, recognized for its broad-spectrum antibiotic properties. It exhibits notable antitumor activity and functions by inhibiting RNA synthesis in vivo. Holomycin serves as a valuable tool in pharmaceutical research, particularly in studies related to antimicrobial resistance and cancer therapeutics. -
Antibiotic
10,11-Dehydrocurvularin is an antibiotic derived from fungi, known for its ability to activate the heat shock response. This compound exhibits significant inhibition of the TGF-β signaling pathway, demonstrating anti-tumorigenic properties. Its biological activities make it a valuable reagent for research in antibiotic efficacy and cancer biology. -
Antitumor Antibiotic
Dinactin is an antibiotic ionophore derived from Streptomyces species, primarily targeting the Wnt/β-catenin signaling pathway in cancer cells. This compound exhibits significant inhibition of HCT-116 cell proliferation, with an IC50 value of 1.1 μM, demonstrating its anti-proliferative effects in an apoptosis-independent manner. Additionally, Dinactin serves as a valuable tool in research related to neuropathic pain. -
Antitumor Antibiotic
Sibiromycin is a glycosylated pyrrolobenzodiazepine (PBD) that functions as a potent antitumor antibiotic. It exerts its biological activity by covalently binding to DNA in the minor groove, specifically targeting the amino group of guanine. This mechanism contributes to its effectiveness in cancer research, making it a valuable tool for studies involving DNA interactions and antitumor mechanisms. -
Antineoplastic Antibiotic
Cytogenin, an antineoplastic antibiotic, demonstrates significant antitumor activity by inhibiting the growth of Ehrlich ascites tumors in mouse models. This compound also regulates inflammatory cytokines, effectively reducing levels of inducible nitric oxide synthase (iNOS), nitric oxide (NO), and interleukin-6 (IL-6) in murine macrophages. Additionally, Cytogenin exhibits antidiabetic effects, making it a valuable reagent for research in cancer biology and inflammation. -
Antibiotic
Fostriecin is a triene antibiotic that primarily targets topoisomerase II and inhibits protein phosphatase PP2A. It exhibits potent antibacterial activity and has been employed in research focused on mechanisms of antibiotic resistance and cancer therapy. Its unique mechanism of action makes it a valuable tool for studying cellular processes related to gene expression and cell cycle regulation. -
Antibiotic
Tigecycline hydrochloride is a broad-spectrum glycylcycline antibiotic that primarily targets bacterial protein synthesis by binding to the 30S ribosomal subunit. It exhibits significant antibacterial activity against a variety of gram-positive and gram-negative pathogens, including Escherichia coli and Acinetobacter baumannii, with mean inhibitory concentrations (MIC) of approximately 125 ng/mL for E. coli and MIC50 and MIC90 values of 1 and 2 mg/L for A. baumannii, respectively. Tigecycline hydrochloride is commonly used in research settings to investigate antibiotic resistance mechanisms and to study the efficacy of antimicrobial agents. -
Antibiotic
DCAP is a broad-spectrum antibiotic that targets the membranes of both Gram-positive and Gram-negative bacteria. It exhibits significant antibacterial activity by disrupting autophagic processes, specifically blocking the maturation of autophagolysosomes and interrupting autophagic flux. This compound is utilized in research applications focused on bacterial infections and autophagy regulation. -
Antibiotic
Tigecycline mesylate is a broad-spectrum glycylcycline antibiotic that targets bacterial protein synthesis. It exhibits significant inhibitory activity against various Gram-positive and Gram-negative bacteria, with a mean inhibitory concentration (MIC) for E. coli (MG1655 strain) of approximately 125 ng/mL. For Acinetobacter baumannii, the MIC50 and MIC90 values are 1 mg/L and 2 mg/L, respectively, making it valuable for research focused on antibiotic resistance and infection control. -
Antibiotic
nTZDpa is a partial agonist of PPARG and functions as an antibiotic. It exhibits significant antibacterial activity, particularly against both growing and persistent strains of Staphylococcus aureus, through the mechanism of lipid bilayer disruption. This compound is valuable for research applications focused on antibiotic resistance and the exploration of novel therapeutic strategies against bacterial infections. -
Antibiotic
CPPD-Q is an antimicrobial agent that primarily targets bacterial pathogens. It demonstrates potent antibacterial activity with an EC50 value of 6.98 mg/L against Vibrio fischeri. Additionally, CPPD-Q exhibits insecticidal properties in Caenorhabditis elegans, where it induces the generation of reactive oxygen species (ROS) in the intestines at concentrations of 1 or 10 µg/mL. This compound is suitable for research applications focused on antimicrobial resistance and the mechanisms of insecticidal action. -
Antibiotic
TAN-420E (Dihydroherbimycin A) is an antibiotic derived from the fermentation of Streptomyces hygroscopicus. This compound demonstrates significant cytotoxicity against P-388 and KB cancer cell lines, highlighting its potential as an anti-cancer agent. In addition, TAN-420E effectively scavenges DPPH free radicals, with an IC50 value of 1.3 μM, indicating its potential antioxidant properties. Research applications include investigations into its antimicrobial and anticancer effects. -
Glycylcycline Antibiotic
Tigecycline hydrate is a glycylcycline antibiotic characterized by its broad-spectrum antibacterial activity. It exhibits significant inhibitory effects against various bacterial strains, with a mean inhibitory concentration (MIC) of approximately 125 ng/mL for E. coli (MG1655 strain). In addition, it displays MIC50 and MIC90 values of 1 mg/L and 2 mg/L, respectively, for Acinetobacter baumannii. This compound is valuable for research applications related to antibiotic efficacy and resistance studies. -
Antibiotic
Rifaquizinone is a hybrid antibiotic that combines the mechanisms of Rifamycin and Quinolone. It effectively inhibits wild-type Staphylococcus aureus RNA polymerase, exhibiting an IC50 value of 34 nM. Rifaquizinone demonstrates potent antibacterial activity against S. aureus infections, with minimum inhibitory concentrations (MICs) ranging from 0.008 to 0.5 μg/mL across 300 clinical isolates of staphylococci and streptococci, making it a valuable tool for antibiotic research and investigation into resistance mechanisms. -
Antibiotic
Erythromycin (aspartate) is a macrolide antibiotic that exerts its effects by binding to the 50S ribosomal subunit of bacteria, inhibiting RNA-dependent protein synthesis through the blockage of transpeptidation and translocation reactions. This compound demonstrates a broad spectrum of antimicrobial activity, making it an important tool in microbiological research. Additionally, erythromycin aspartate has shown potential antitumor and neuroprotective properties, expanding its applications in various fields of biomedical research. -
Antibiotic
Alatrofloxacin is a fluoronaphthyridone antibiotic that serves as a proagent of Trovafloxacin. Its primary mechanism involves the inhibition of DNA synthesis in pathogenic organisms, resulting in effective antimicrobial activity. In addition to its antibacterial properties, Alatrofloxacin also exhibits immunosuppressive effects, making it relevant for research applications in studying immune responses and infectious diseases. -
Antibiotic
Ficellomycin is a nitrogen-containing bicyclic antibiotic targeting Gram-positive bacteria, including multidrug-resistant Staphylococcus aureus. It exerts its biological activity by inducing the formation of defective 34S DNA fragments that disrupt the semi-conservative DNA replication process. These fragments are unable to integrate into larger DNA segments, ultimately hindering the assembly of a complete bacterial chromosome. Ficellomycin is valuable for research on bacterial diseases and antibiotic resistance mechanisms. -
Tetracycline derivatives of antibiotic
Sarecycline is a narrow-spectrum tetracycline derivative antibiotic that primarily targets bacterial protein synthesis by interfering with tRNA accommodation and stabilizing mRNA binding to the 70S ribosome. It exhibits significant anti-inflammatory activity and effectively inhibits the growth of Gram-positive bacteria, including various strains of keratobacterium acnes. Sarecycline is suitable for research applications focused on understanding moderate to severe acne and its underlying mechanisms. -
Fluoroquinolone Antibiotic
PD 124816 is an orally active fluoroquinolone antibiotic that inhibits DNA gyrase (topoisomerase IV), providing broad-spectrum antibacterial activity. It demonstrates efficacy against both Gram-positive and Gram-negative bacteria, with a minimum inhibitory concentration (MIC₉₀) of ≤ 0.06 μg/mL and an MIC₉₀ of 1 μg/mL for anaerobic bacteria such as Peptostreptococcus fragi. Additionally, PD 124816 exhibits complete bactericidal effectiveness in a mouse model of Mycobacterium leprae infection. This compound is valuable for research involving mixed infections and antibiotic resistance mechanisms. -
Antitumor Antibiotic
Esperamicin A1 is a highly potent antitumor antibiotic derived from Actinomadura verrucosospora. It exhibits significant cytotoxic activity, making it valuable for cancer research applications. In addition to its antitumor properties, Esperamicin A1 functions as a click chemistry reagent, featuring an alkyne group that enables copper-catalyzed azide-alkyne cycloaddition (CuAAc) with azide-containing molecules. This allows for versatile applications in bioconjugation and molecular imaging studies. -
Antibiotic
Ibezapolstat hydrochloride is a novel, orally active inhibitor of DNA polymerase IIIC (pol IIIC) with a Ki of 0.325 μM specific to the enzyme from Clostridium difficile. This compound exhibits antibiotic activity and is primarily utilized in research focused on Clostridium difficile infections (CDI). Its unique mechanism makes it a valuable tool for studying CDI and developing potential therapeutic strategies. -
Antibiotic
Alatrofloxacin mesylate is a broad-spectrum antibiotic that targets and inhibits bacterial growth. It demonstrates significant hydrophilicity in aqueous solutions, facilitating the formation of stable suspensions. Understanding its degradation products, which can become hydrophobic upon exposure, is essential for maintaining long-term stability, as this affects particle aggregation. Additionally, variations in surface tension characteristics under different lighting conditions can influence the physical and chemical properties of Alatrofloxacin mesylate, making it a valuable candidate for research into antibiotic efficacy and stability. -
Antibiotics
4-Demethoxy-7,9-di-epi-daunorubicin is an anthracycline antibiotic that targets DNA by intercalating into the double helix, forming stable complexes with calf thymus DNA. Its primary activity includes the inhibition of prokaryotic nucleic acid polymerases, such as E. coli DNA polymerase I and RNA polymerase. This compound is particularly useful in cancer research and investigations into bacterial infections, providing insights into therapeutic mechanisms and potential treatment strategies. -
Antibiotic
Erythromycin A dihydrate is a macrolide antibiotic that targets the bacterial 50S ribosomal subunit, effectively inhibiting RNA-dependent protein synthesis through the blockage of transpeptidation and translocation reactions. It possesses a broad spectrum of antimicrobial activity and is commonly used in microbiological research. Additionally, Erythromycin A dihydrate has demonstrated antitumor and neuroprotective effects, making it valuable for diverse applications in biological research. -
Antibiotic
Erythromycin stearate is a macrolide antibiotic that targets bacterial 50S ribosomal subunits, leading to the inhibition of RNA-dependent protein synthesis through the blockage of transpeptidation and translocation reactions. It exhibits a broad spectrum of antimicrobial activity against various gram-positive and some gram-negative bacteria. In addition to its antibacterial properties, erythromycin stearate has been investigated for its potential antitumor and neuroprotective effects, making it suitable for diverse research applications in microbiology and cancer studies. -
Antibiotic
Eponemycin is an antibiotic with significant antitumor properties, targeting cancer cell proliferation. It demonstrates potent cytotoxicity against various cancer cell lines including B16-F10, L1210, P388, and HCT-116, with IC50 values of 0.0017, 0.01, 0.031, and 0.0097 µg/mL, respectively. Additionally, Eponemycin effectively inhibits DNA synthesis in the B16-F10 cell line, exhibiting an IC50 of 0.1 µg/mL, thereby demonstrating its utility in cancer research applications focused on DNA replication and cell viability. -
Antitumor Antibiotic
2-Hydroxyaclacinomycin A is an anthracycline antibiotic that exerts its antitumor effects through the inhibition of RNA and DNA synthesis. It demonstrates potent cytotoxic activity against leukemia L-1210 cells, with IC50 values of 0.10 μg/mL and 0.95 μg/mL for RNA and DNA synthesis, respectively. This compound is valuable for research focused on cancer therapeutics and the cellular mechanisms of anthracycline antibiotics. -
Antitumor Antibiotic
1-Hydroxyoxaunomycin is an antitumor antibiotic that targets cellular proliferation. It effectively inhibits U210 cell growth, demonstrating IC50 values of 0.0005 μg/mL for cell growth, 1.00 μg/mL for DNA synthesis, and 0.76 μg/mL for RNA synthesis. This compound is primarily utilized in cancer research to explore mechanisms of action related to nucleic acid synthesis and cellular function. -
Antibiotic
Erythromycin glutamate is a macrolide antibiotic that primarily targets bacterial 50S ribosomal subunits, inhibiting RNA-dependent protein synthesis by blocking transpeptidation and translocation reactions. This compound demonstrates a broad spectrum of antimicrobial activity against various bacterial pathogens. In addition to its antibiotic properties, erythromycin glutamate has shown potential antitumor and neuroprotective effects, making it valuable for diverse research applications in microbiology, oncology, and neurobiology. -
AntibioticAgent
GSK299423 is an antibiotic agent primarily targeting DNA gyrase. It exhibits potent inhibition of supercoiling in Staphylococcus aureus with an IC50 of 14 nM and in Escherichia coli with an IC50 of 100 nM. This compound is suitable for research applications focused on antibacterial mechanisms and the evaluation of DNA-targeting therapies. -
Antibiotic
Viquidacin is an antibiotic that primarily targets topoisomerase IV and DNA gyrase. It demonstrates significant antibacterial activity against gram-positive bacteria, particularly Staphylococcus aureus, by inhibiting supercoiling, decatenation, and relaxation processes. Viquidacin also exhibits activity against Escherichia coli and shows a minimum inhibitory concentration (MIC) range of 2-128 mg/L against wild-type and mutant strains of S. aureus, making it a valuable reagent for antibacterial research applications. -
Antibiotic
Erythromycin hydrochloride is a macrolide antibiotic that acts as a protein synthesis inhibitor, targeting bacterial ribosomes. It demonstrates broad-spectrum activity against both Gram-positive and some Gram-negative bacteria, making it effective in treating various bacterial infections, including respiratory and skin infections. Additionally, erythromycin hydrochloride has been implicated in the inhibition of mammalian mRNA splicing, indicating potential roles in research related to gene expression and cellular function. This compound is widely utilized in biomedical research for its antibacterial properties and mechanisms. -
Antibiotic
Luisol A is an anthraquinone antibiotic analog derived from an aromatic tetraol, recognized as a major metabolite of Streptomyces, a marine actinomycete. This compound exhibits significant antibacterial activity, making it a valuable tool in the study of antibiotic mechanisms and resistance. Its application in research aids in the exploration of novel antimicrobial agents and their effects on various bacterial strains. -
Antibiotic
Agrochelin is an alkaloid antibiotic with cytotoxic properties, derived from the fermentation of marine Agrobacterium species. This compound exhibits significant cytotoxic activity against various tumor cell lines, making it a valuable tool in cancer research. Agrochelin's mechanism of action may provide insights into antibiotic efficacy and the development of novel therapeutic strategies for oncological applications. -
Antibiotic Agent
Polyketomycin is a tetracyclic quinone glycoside antibiotic derived from Streptomyces sp. or Streptomyces diastatochromogenes, targeting Gram-positive bacteria with a minimal inhibitory concentration (MIC) of less than 0.2 µg/mL. This compound exhibits notable antibacterial, anticancer, and antimalarial activities, making it a valuable tool in microbiological and pharmacological research. Its diverse biological applications support investigations in antibiotic efficacy, cancer treatment, and antimalarial drug development. -
Antitumor Antibiotic
Sandramycin is a cyclic depsipeptide antibiotic with a primary mechanism of action as an antitumor agent. It exhibits potent DNA intercalation and binding, functioning effectively as a cytotoxin in antibody-drug conjugates (ADCs). Sandramycin demonstrates significant activity against Gram-positive bacteria and is recognized for its strong antitumor efficacy, making it a valuable reagent for cancer research and the development of targeted therapies. -
Nucleoside Antibiotic
Dealanylascamycin is a nucleoside antibiotic that functions as a carbonic anhydrase (CA) inhibitor, exhibiting Ki values of 167, 65.2, 234, and 143 nM for human CA isoforms I, II, IV, and IX, respectively. This compound demonstrates broad-spectrum antibacterial activity, notably effective against pathogens such as Xanthomonas citri with a minimum inhibitory concentration (MIC) of 0.4 μg/mL. Additionally, Dealanylascamycin displays significant cytotoxicity, making it a substance of interest for various biological research applications, particularly in the study of antimicrobial effects and CA inhibition. -
Antibiotic Adjuvant
PA3552-IN-1 is an antibiotic adjuvant that enhances the efficacy of Polymyxin B against multidrug-resistant Pseudomonas aeruginosa, specifically the DK2 strain. By reducing the expression of the PA3552 gene, PA3552-IN-1 restores bacterial sensitivity, making it a valuable tool for overcoming antimicrobial resistance. This compound is relevant for research applications aimed at developing strategies for treating resistant bacterial infections. -
Sulfonamide Antibiotic
Sulfadimethoxine-d4 is a deuterium-labeled sulfonamide antibiotic, derived from sulfadimethoxine. This compound exhibits broad-spectrum antimicrobial activity and is utilized in the treatment of various infections, including respiratory, urinary tract, enteric, and soft tissue infections. Sulfadimethoxine-d4 serves as a valuable tool in pharmacokinetic studies and metabolic research involving sulfonamide antibiotics. -
Antibiotic
Erythromycin-13C2 is a macrolide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit. It exhibits significant antibacterial activity against a variety of gram-positive and some gram-negative bacteria. This compound is primarily utilized in microbiological research and can be instrumental in studies investigating antibiotic resistance and the mechanisms of bacterial infections. -
Antibiotics
Dienone B is a marine algicide that demonstrates antibiotic activity against both Gram-positive and Gram-negative marine bacteria. Its unique chemical structure allows it to effectively inhibit bacterial growth, making it a valuable tool for researchers studying marine microbiology and developing new antimicrobial agents for use in aquaculture and environmental applications. Further investigations may explore its potential roles in combating marine biofouling and preserving marine resources.
